Kerry Coffee

Kerry has over 15 years experience partnering with entrepreneurs and established companies in healthcare and the life sciences to enter new markets. Her specialty lies in understanding market need, and through this lens evaluating new products, technologies and delivery models for their ability to advance the standard of care.

Starting her consulting career in Accenture’s Strategy practice, Kerry worked with life science clients and hospital systems to evaluate, commercialize and market new products and technologies. As SVP of Consulting Services for Fallon Medica LLC she built a successful consulting practice focused on market development for orphan and immuno-oncology therapies. Kerry started Schiller Discovery in 2015 with the strong desire to more directly address healthcare’s challenges through partnerships with emerging, innovative organizations in the healthcare space. 

Kerry has advised clients including the Cleveland Clinic, Amgen, Merck, Pinnacle Biologics and Pfizer. She holds a BA from the College of William and Mary and an MBA from Columbia Business School and London Business School. Prior to her consulting career she was a Research Fellow in the Dept. of Nuclear Medicine at Memorial Sloan Kettering Cancer Center.  She currently is a guest lecturer and mentor at Weill Cornell's BioVenture program.